US seeking more transparency from pharma
R Collier - 2016 - Can Med Assoc
The United States government is “deeply concerned” about the rising costs of drugs and is
seeking greater transparency from pharmaceutical companies, states the administration's …
seeking greater transparency from pharmaceutical companies, states the administration's …
Ontario delays implementation of pharma transparency rules
B Owens - 2019 - Can Med Assoc
The Ontario government is putting off the implementation of rules that would require
pharmaceutical companies and medical device makers to report all payments and gifts to …
pharmaceutical companies and medical device makers to report all payments and gifts to …
Generic Group Joins BIO, PhRMA To Oppose Maryland Transparency Bill
N Florko - Inside CMS, 2017 - JSTOR
As federal and state lawmakers increasingly look to transparency as a way to stem drug
price increases, the generic drug trade group has joined with the brand and biotech groups …
price increases, the generic drug trade group has joined with the brand and biotech groups …
CMMI Chief Not Worried If ACOs Drop Out, Says Others Will Step Up
MM Stein - Inside CMS, 2018 - JSTOR
INSIDE CMS—www. InsideHealthPolicy. com—October 11, 2018 4 is a key way that states
could lower drug costs.“As a result, a number of states have been pursuing legislative …
could lower drug costs.“As a result, a number of states have been pursuing legislative …
Enhancing transparency at the US Food and Drug Administration: moving beyond the 21st century cures act
JM Sharfstein, M Stebbins - JAMA, 2017 - jamanetwork.com
The US Food and Drug Administration (FDA) has primary responsibility for oversight of every
drug, biologic, and medical device sold in the United States. Yet the FDA is far more than a …
drug, biologic, and medical device sold in the United States. Yet the FDA is far more than a …
Biotech therapies face disclosure requirements; broader transparency in product prices and payments to researchers aim to curb conflicts of interest and rationalize …
J Wechsler - Biopharm International, 2009 - go.gale.com
Transparency is the hot buzzword in Washington these days. Soon after g. his swearing-in
on January 20, 2009, President Barack Obama issued a memorandum to all federal …
on January 20, 2009, President Barack Obama issued a memorandum to all federal …
[CITATION][C] Dozens Of States Have Bills Filed To Hike Drug Cost Transparency
E Durkin - InsideHealthPolicy. com's FDA Week, 2016 - JSTOR
[CITATION][C] CA Drug Makers Blame PBMs, Issuers In Bid To Quash Transparency Bill
A Lotven - InsideHealthPolicy. com's FDA Week, 2017 - JSTOR
[CITATION][C] Public Can Seek Info On Drug Price Hikes Under CA Transparency Law
R Cohrs - Inside CMS, 2019 - JSTOR
[CITATION][C] Transparency on Prescription Drug Research Expenditures
A Sarpatwari, J Avorn, AS Kesselheim
